Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Province ASEAN Pharmaceutical is a Chinese pharmaceutical company headquartered in Changchun, Jilin Province. Established in 2003, the company specializes in the research, development, and manufacturing of both chemical pharmaceuticals and traditional Chinese medicine (TCM) products. Its portfolio includes a variety of oral dosage forms such as tablets, capsules, and granules, targeting therapeutic areas like cardiovascular health, respiratory diseases, and infectious diseases. The company operates GMP-certified production facilities and primarily serves the domestic Chinese healthcare market. Key products in its commercial lineup include Ginkgo Biloba tablets and Roxithromycin capsules.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Province ASEAN Pharmaceutical.